Urology · Brooklyn, NY
NPI
1922213032
Since 2007
Specialty
Urology
Code 208800000X
Group practices
7
Medicare group memberships
Hospitals
1
Hospital affiliations
121 Dekalb Ave, Urology Dept.
Brooklyn, NY, 11201
Phone (718) 250-6880
Groups this clinician bills Medicare through
Medicare paid, 2024
$231K
3,737 services
Medicare patients, 2024
431
Average age 74
Drug cost, 2024
$2.0M
2,043 prescriptions
Company payments, 2025
$1,165
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alexander Lipyansky was code 99213 (office e&m - established), 332 times for 220 patients. In total Alexander Lipyansky billed 3,737 services in 114 codes, and Medicare paid $231K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-06-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 332 | 220 | $76.28 | $25K |
| 36415 Venipuncture Blood Collection | Office | 235 | 150 | $8.65 | $2,033 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 204 | 56 | $49.46 | $10K |
| 99214 Office E&M - Established | Office | 168 | 125 | $109.17 | $18K |
| 51741 Test - Miscellaneous | Office | 133 | 114 | $7.14 | $949 |
| 51798 Ultrasound - Nonspecific | Office | 113 | 93 | $10.32 | $1,166 |
| 51784 Neurologic | Office | 112 | 98 | $27.71 | $3,103 |
| 51728 Other Organ Systems | Office | 109 | 95 | $327.28 | $36K |
| 64566 Musculoskeletal | Office | 96 | 42 | $104.00 | $9,984 |
| 52000 Cystourethroscopy | Office | 89 | 85 | $216.45 | $19K |
| 96402 Chemotherapy Administration | Office | 78 | 34 | $29.78 | $2,323 |
| 80053 Clinical Chemistry | Office | 78 | 57 | $10.35 | $807 |
| 81002 Clinical Chemistry | Office | 67 | 59 | $3.41 | $228 |
| 84403 Clinical Chemistry | Office | 63 | 45 | $25.29 | $1,593 |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 53 | 53 | $98.26 | $5,208 |
By year: 2022 $304K for 3,298 services; 2023 $193K for 2,926 services; 2024 $231K for 3,737 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 235 | 150 | $8.65 | $2,033 |
| 80053 Clinical Chemistry | 78 | 57 | $10.35 | $807 |
| 81002 Clinical Chemistry | 67 | 59 | $3.41 | $228 |
| 84403 Clinical Chemistry | 63 | 45 | $25.29 | $1,593 |
| 84100 Clinical Chemistry | 50 | 40 | $4.65 | $233 |
| 84550 Clinical Chemistry | 50 | 40 | $4.43 | $222 |
| 83735 Clinical Chemistry | 50 | 40 | $6.57 | $329 |
| 83615 Clinical Chemistry | 49 | 39 | $5.92 | $290 |
| 85025 Blood Count | 39 | 27 | $7.61 | $297 |
| 80048 Clinical Chemistry | 19 | 19 | $8.29 | $158 |
Medicare prescription drug claims, 2024
In 2024, the drug Alexander Lipyansky prescribed most often to Medicare patients was Tamsulosin Hcl, with 506 prescriptions and refills. In total Alexander Lipyansky wrote 2,043 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 506 | 1,032 | 191 | $5,093 |
| Gemtesa Vibegron | 346 | 384 | 103 | $179K |
| Lupron Depot Leuprolide Acetate | 220 | 676 | 81 | $1.3M |
| Finasteride Generic | 175 | 335 | 58 | $1,523 |
| Alfuzosin Hcl Er Alfuzosin Hcl | 116 | 140 | 33 | $1,220 |
| Ciprofloxacin Hcl Generic | 103 | 103 | 89 | $352 |
| Oxybutynin Chloride Generic | 86 | 110 | 34 | $980 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 74 | 74 | 64 | $181 |
| Bicalutamide Generic | 68 | 74 | 28 | $803 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 52 | 56 | 23 | $953 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 30 | 30 | Under 11 | $263 |
| Myrbetriq Mirabegron | 28 | 38 | Under 11 | $17K |
| Potassium Citrate Er Potassium Citrate | 26 | 34 | Under 11 | $838 |
| Celecoxib Generic | 23 | 23 | Under 11 | $395 |
| Silodosin Generic | 21 | 31 | Under 11 | $1,268 |
Brand drugs: - claims; generic drugs: 1,385 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alexander Lipyansky $1,165 ($1,165 in general payments such as food, travel and fees) from 8 companies. The largest payer was Medtronic, Inc. with $485.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.